A
Ann Horton
Researcher at American Institutes for Research
Publications - 3
Citations - 7056
Ann Horton is an academic researcher from American Institutes for Research. The author has contributed to research in topics: Randomized controlled trial & Systematic review. The author has an hindex of 3, co-authored 3 publications receiving 6697 citations.
Papers
More filters
Journal ArticleDOI
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents
Bonita Falkner,Stephen R. Daniels,Joseph T. Flynn,Samuel S. Gidding,Lee A. Green,Julie R. Ingelfinger,Ronald M. Lauer,Bruce Z. Morgenstern,Ronald J. Portman,Ronald J. Prineas,Albert P. Rocchini,Bernard Rosner,Alan R. Sinaiko,Nicolas Stettler,Elaine M. Urbina,Edward J. Roccella,Tracey R. Hoke,Carl E. Hunt,Gail D. Pearson,Joanne Karimbakas,Ann Horton +20 more
Journal ArticleDOI
Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Barbara P. Yawn,George R. Buchanan,Araba Afenyi-Annan,Samir K. Ballas,Kathryn L. Hassell,Andra H. James,Lanetta B. Jordan,Sophie Lanzkron,Richard Lottenberg,William J. Savage,Paula Tanabe,Russell E. Ware,M. Hassan Murad,Jonathan C. Goldsmith,Jonathan C. Goldsmith,Eduardo Ortiz,Robinson Fulwood,Ann Horton,Joylene John-Sowah +18 more
TL;DR: Hydxyurea and transfusion therapy are strongly recommended for many individuals with SCD and many other recommendations are based on quality of evidence that is less than high due to the paucity of clinical trials regarding screening, management, and monitoring for individuals withSCD.
Journal ArticleDOI
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members
Barbara P. Yawn,George R. Buchanan,Araba Afenyi-Annan,Samir K. Ballas,Kathryn L. Hassell,Andra H. James,Lanetta B. Jordan,Sophie Lanzkron,Richard Lottenberg,William J. Savage,Paula Tanabe,Russell E. Ware,M. Hassan Murad,Jonathan C. Goldsmith,Eduardo Ortiz,Robinson Fulwood,Ann Horton,Joylene John-Sowah +17 more
TL;DR: Findings in this large single-institution cohort study support the continued use of the ASA-PS scale as a measure of preoperative health status and suggest it may be a useful risk-stratification tool.